| NCT ID | NCT07170072 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Overdose |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-07-23 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-07-23 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study will use mixed methods research to examine overdose and other health-related impacts of harm reduction initiatives in NYC homeless shelters.
Eligibility Criteria
Inclusion Criteria: For Aims 1a, 1b, and 2: There will be no participant enrollment or direct contact with individuals as these aims will involve the use of an analytic dataset comprised of linked administrative NYC homeless services, Medicaid, and vital records. The dataset will include records for individuals who entered the NYC DHS single-adult shelter system during calendar years 2021-2026, as well as a matched comparison group(s) (as identified through Medicaid data) during the same years. The matched comparison group will be comprised of individuals age 18 and older with active Medicaid coverage at the time of observation. For Aim 3 Homeless Services Client participant group: To be eligible for participation in this study, an individual must meet all of the following criteria: * Adult 18 year of age or older * Speak English * Is staying or has stayed in an NYC single-adult shelter that has implemented HRSP interventions * Report past-year drug use * Able and willing to provide consent For Aim 3 Homeless Services Staff participant group: To be eligible for participation in this study, an individual must meet all of the following criteria: * 18 years of age or older * Speak English * Works at an adult shelter service provider agency that implemented HRSP or received HRSP interventions (role may include case manager, security staff, shelter director, medical staff, organizational leadership) * Able and willing to provide consent For Aim 3 Homeless Services Stakeholder participant group: To be eligible for participation in this study, an individual must meet all of the following criteria: * 18 years of age or older * Speak English * Works in a role in which they have key insight to the HRSP interventions, including planning and implementation (role may include homeless services administrator or other key stakeholder) * Able and willing to provide consent Exclusion Criteria: Aims 1a, 1b, and 2: Children under age 18 years of age will be excluded. Aim 3: Under age 18 years old, currently a prisoner (we are not sampling from locations where we expect to encounter prisoners), unable to communicate in English (because the interview and focus group guides will not be validated for use in other languages), and unable to provide informed consent. For Aim 3 Homeless Services Client participant group: those who are not staying or have not stayed at a shelter with HRSP interventions and those who do not report past-year drug use will not be excluded. For Aim 3 Homeless Services Staff participant group: those who have not been employed in a shelter with the HRSP interventions will be excluded. In alignment with standard techniques of purposeful sampling and the study goal of ensuring a range of experiences is captured in the qualitative interviews, additional targeting or exclusion criteria might be set by investigators as needed to ensure that a diverse range of experiences is included among qualitative interview participants.
Contact & Investigator
Bennett Allen, PhD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT07170072 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Overdose. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07170072 currently recruiting?
Yes, NCT07170072 is actively recruiting participants. Contact the research team at Bennett.Allen@nyulangone.org for enrollment information.
Where is the NCT07170072 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07170072 clinical trial?
NCT07170072 is sponsored by NYU Langone Health. The principal investigator is Bennett Allen, PhD at NYU Langone Health. The trial plans to enroll 80 participants.